ClinicalTrials.Veeva

Menu

Cerebral Antibiotics Distribution After Acute Brain Injury

P

Poitiers University Hospital

Status and phase

Completed
Phase 1

Conditions

Brain Injury
Bacterial Infection

Treatments

Drug: Ciprofloxacin
Drug: cefotaxime
Drug: Fosfocine
Drug: Metronidazole

Study type

Interventional

Funder types

Other

Identifiers

NCT01059890
A-BRAIN

Details and patient eligibility

About

The aim of the study is to explore the distribution of antibiotics in the brain after an acute brain injury because brain infections treatment is still an health care problem.

Enrollment

18 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute brain injury
  • Patient who receive an antibiotic for an infection or prophylaxy
  • Glasgow coma score < 8

Exclusion criteria

  • Age < 18 years old
  • Pregnant woman
  • HCV, HIV, HBV infection

Trial design

18 participants in 4 patient groups

Cefotaxime
Experimental group
Treatment:
Drug: cefotaxime
Metrodinazole
Experimental group
Treatment:
Drug: Metronidazole
Ciprofloxacine
Experimental group
Treatment:
Drug: Ciprofloxacin
Fosfocine
Experimental group
Treatment:
Drug: Fosfocine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems